Republished Education in Heart: New P2Y₁₂ inhibitorsSTOREY, Robert F.Postgraduate medical journal. 2012, Vol 88, Num 1035, pp 49-54, issn 0032-5473, 6 p.Article

Bleeding manifestations of congenital and drug-induced defects of the platelet P2Y₁₂ receptor for adenosine diphosphateCATTANEO, Marco.Thrombosis and haemostasis. 2011, Vol 105, issn 0340-6245, S67-S74, SUP1Article

Variability of response to antiplatelet therapySTOREY, Robert F.European heart journal supplements. 2008, Vol 10, Num A, issn 1520-765X, A21-A27Conference Paper

Platelet function testing and prediction of procedural bleeding risk : High on-treatment platelet reactivityGROVE, Erik L; HOSSAIN, Rashed; STOREY, Robert F et al.Thrombosis and haemostasis. 2013, Vol 109, Num 5, pp 817-824, issn 0340-6245, 8 p.Article

Development and Clinical use of Prasugrel and TicagrelorAHMAD, Shiraz; STOREY, Robert F.Current pharmaceutical design (Print). 2012, Vol 18, Num 33, pp 5240-5260, issn 1381-6128, 21 p.Article

Platelets, inflammation and tissue regenerationNURDEN, Alan T.Thrombosis and haemostasis. 2011, Vol 105, issn 0340-6245, S13-S33, SUP1Article

Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y₁₂ and P2Y₁ antagonists but not aspirinSTOREY, Robert F; MAY, Jane A; HEPTINSTALL, Stan et al.Thrombosis research. 2005, Vol 115, Num 4, pp 301-307, issn 0049-3848, 7 p.Article

Comparison of two murine models of thrombosis induced by atherosclerotic plaque injuryHECHLER, Beatrice; GACHET, Christian.Thrombosis and haemostasis. 2011, Vol 105, issn 0340-6245, S3-S12, SUP1Article

Clinical experience with antithrombotic drugs acting on purine receptor pathwaysSTOREY, Robert F.Drug development research. 2001, Vol 52, Num 1-2, pp 202-212, issn 0272-4391Conference Paper

Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) TrialMAHAFFEY, Kenneth W; HELD, Claes; KHURMI, Nardev S et al.Journal of the American College of Cardiology. 2014, Vol 63, Num 15, pp 1493-1499, issn 0735-1097, 7 p.Article

ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)CATAPANO, Alberico L; REINER, Zeljko; ERDINE, Serap et al.Atherosclerosis. 2011, Vol 217, Num 1, pp 3-46, issn 0021-9150, 44 p.Article

The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: Combined analysis of the ONSET/OFFSET and RESPOND studiesBLIDEN, Kevin P; TANTRY, Udaya S; STOREY, Robert F et al.The American heart journal. 2011, Vol 162, Num 1, pp 160-165, issn 0002-8703, 6 p.Article

Bleeding complications with the P₂Y₁₂ receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trialBECKER, Richard C; PIERRE BASSAND, Jean; LOPEZ-SENDON, Jose et al.European heart journal. 2011, Vol 32, Num 23, pp 2933-2944, issn 0195-668X, 12 p.Article

Pulmonary Function in Patients With Acute Coronary Syndrome Treated With Ticagrelor or Clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] Pulmonary Function Substudy)STOREY, Robert F; BECKER, Richard C; CANNON, Christopher P et al.The American journal of cardiology. 2011, Vol 108, Num 11, pp 1542-1546, issn 0002-9149, 5 p.Article

First Analysis of the Relation Between CYP2C19 Genotype and Pharmacodynamics in Patients Treated With Ticagrelor Versus Clopidogrel The ONSET/OFFSET and RESPOND Genotype StudiesTANTRY, Udaya S; BLIDEN, Kevin P; WEI, Cheryl et al.Circulation. Cardiovascular genetics (Print). 2010, Vol 3, Num 6, pp 556-566, issn 1942-325X, 11 p.Article

Ticagrelor Effectively and Reversibly Blocks Murine Platelet P2Y_12-Mediated Thrombosis and Demonstrates a Requirement for Sustained P2Y₁₂ Inhibition to Prevent Subsequent Neointima : PlateletsPATIL, Shankar B; JACKMAN, Laura E; FRANCIS, Sheila E et al.Arteriosclerosis, thrombosis, and vascular biology. 2010, Vol 30, Num 12, pp 2385-2391, issn 1079-5642, 7 p.Article

Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y₁₂ receptor antagonist, compared with clopidogrel in patients with acute coronary syndromesSTOREY, Robert F; HUSTED, Steen; CANNON, Christopher P et al.Journal of the American College of Cardiology. 2007, Vol 50, Num 19, pp 1852-1856, issn 0735-1097, 5 p.Article

Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factorWARD, Jon R; BINGLE, Lynne; JUDGE, Heather M et al.Thrombosis and haemostasis. 2005, Vol 94, Num 4, pp 831-838, issn 0340-6245, 8 p.Article

Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non-ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization: A Substudy From the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) TrialWALLENTIN, Lars; LINDHOLM, Daniel; HELD, Claes et al.Circulation (New York, N.Y.). 2014, Vol 129, Num 3, pp 293-303, issn 0009-7322, 11 p.Article

Vorapaxar in Acute Coronary Syndrome Patients Undergoing Coronary Artery Bypass Graft Surgery: Subgroup Analysis From the TRACER Trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)WHELLAN, David J; TRICOCI, Pierluigi; RUZYLLO, Witold et al.Journal of the American College of Cardiology. 2014, Vol 63, Num 11, pp 1048-1057, issn 0735-1097, 10 p.Article

Prehospital Ticagrelor in ST-Segment Elevation Myocardial InfarctionMONTALESCOT, Gilles; VAN'T HOF, Arnoud W; HAMMETT, Christopher J et al.The New England journal of medicine. 2014, Vol 371, Num 11, pp 1016-1027, issn 0028-4793, 12 p.Article

Health-Related Quality of Life of Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes—Results from the PLATO TrialLEVIN, Lars-Ake; WALLENTIN, Lars; BERNFORT, Lars et al.Value in health. 2013, Vol 16, Num 4, pp 574-580, issn 1098-3015, 7 p.Article

Hirudin anticoagulation allows more rapid determination of P2Y₁₂ inhibition by the VerifyNow P2Y12 assaySUMAYA, Wael; DALY, Rebecca L; MEHRA, Sonal et al.Thrombosis and haemostasis. 2013, Vol 109, Num 3, pp 550-555, issn 0340-6245, 6 p.Article

ST-Elevation Acute Coronary Syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) Trial: Insights From the ECG SubstudyARMSTRONG, Paul W; SIHA, Hany; HARRINGTON, Robert A et al.Circulation (New York, N.Y.). 2012, Vol 125, Num 3, pp 514-521, issn 0009-7322, 8 p.Article

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic AttackJAMES, Stefan K; STOREY, Robert F; PAIS, Prem et al.Circulation (New York, N.Y.). 2012, Vol 125, Num 23, pp 2914-2921, issn 0009-7322, 8 p.Article